Author: Kumar, Andre; Weng, Yingjie; Graglia, Sally; Chung, Sukyung; Duanmu, Youyou; Lalani, Farhan; Gandhi, Kavita; Lobo, Viveta; Jensen, Trevor; Nahn, Jeffrey; Kugler, John
Title: Interobserver Agreement of Lung Ultrasound Findings of COVIDâ€19 Cord-id: 6op5ww0d Document date: 2021_1_11
ID: 6op5ww0d
Snippet: BACKGROUND: Lung ultrasound (LUS) has received considerable interest in the clinical evaluation of patients with COVIDâ€19. Previously described LUS manifestations for COVIDâ€19 include Bâ€lines, consolidations, and pleural thickening. The interrater reliability (IRR) of these findings for COVIDâ€19 is unknown. METHODS: This study was conducted between March and June 2020. Nine physicians (hospitalists: n = 4; emergency medicine: n = 5) from 3 medical centers independently evaluated n = 20 L
Document: BACKGROUND: Lung ultrasound (LUS) has received considerable interest in the clinical evaluation of patients with COVIDâ€19. Previously described LUS manifestations for COVIDâ€19 include Bâ€lines, consolidations, and pleural thickening. The interrater reliability (IRR) of these findings for COVIDâ€19 is unknown. METHODS: This study was conducted between March and June 2020. Nine physicians (hospitalists: n = 4; emergency medicine: n = 5) from 3 medical centers independently evaluated n = 20 LUS scans (n = 180 independent observations) collected from patients with COVIDâ€19, diagnosed via RTâ€PCR. These studies were randomly selected from an image database consisting of COVIDâ€19 patients evaluated in the emergency department with portable ultrasound devices. Physicians were blinded to any patient information or previous LUS interpretation. Kappa values (κ) were used to calculate IRR. RESULTS: There was substantial IRR on the following items: normal LUS scan (κ = 0.79 [95% CI: 0.72–0.87]), presence of Bâ€lines (κ = 0.79 [95% CI: 0.72–0.87]), ≥3 Bâ€lines observed (κ = 0.72 [95% CI: 0.64–0.79]). Moderate IRR was observed for the presence of any consolidation (κ = 0.57 [95% CI: 0.50–0.64]), subpleural consolidation (κ = 0.49 [95% CI: 0.42–0.56]), and presence of effusion (κ = 0.49 [95% CI: 0.41–0.56]). Fair IRR was observed for pleural thickening (κ = 0.23 [95% CI: 0.15–0.30]). DISCUSSION: Many LUS manifestations for COVIDâ€19 appear to have moderate to substantial IRR across providers from multiple specialties utilizing differing portable devices. The most reliable LUS findings with COVIDâ€19 may include the presence/count of Bâ€lines or determining if a scan is normal. Clinical protocols for LUS with COVIDâ€19 may require additional observers for the confirmation of less reliable findings such as consolidations.
Search related documents:
Co phrase search for related documents- Try single phrases listed below for: 1
Co phrase search for related documents, hyperlinks ordered by date